GlassScriptPhysician profile
Jocelyn Carlo
NPI 1346235322
$23,455.83
in general payments reported to CMS, 2019-2025
25 companies · $6,163 in 2025
The $6,163 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $64.96 · 2021: $43.02 · 2022: $3,628 · 2023: $5,171 · 2024: $7,746 · 2025: $6,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $4,916 · Education: $3,250 · Gift: $59.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,854.53 |
| Food and Beverage | $4,915.85 |
| Education | $3,250.00 |
| Gift | $59.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,969.29 | 2022-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $447.69 | 2019-2025 | Coolseal Generator, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Davol INC. | $278.11 | 2021-2025 | Arista, Phasix Mesh |
| Abbvie INC. | $238.21 | 2019-2023 | Lo Loestrin Fe |
| Gynesonics, INC. | $215.30 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $199.19 | 2019-2025 | |
| Astellas Pharma US INC | $149.57 | 2019-2025 | Veozah |
| Allergan, INC. | $127.93 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $122.18 | 2022-2024 | |
| Medtronic, INC. | $99.86 | 2022 | |
| Sumitomo Pharma America, INC. | $96.60 | 2023-2025 | Myfembree |
| Medtronic USA, INC. | $86.76 | 2019 | |
| Organon LLC | $62.94 | 2024-2025 | Nexplanon |
| Pfizer INC. | $62.26 | 2019-2024 | |
| Evofem Biosciences, INC. | $58.34 | 2022-2025 | Phexxi, Solosec, Phexx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $56.33 | 2019-2022 | |
| Millicent US INC | $41.18 | 2019-2025 | Femlyv, Intrarosa |
| Vertical Pharmaceuticals, LLC | $28.91 | 2019 | |
| Fujifilm New Development USA, INC. | $26.50 | 2019 | |
| Olympus America INC. | $17.45 | 2019 | |
| Smith+Nephew, INC. | $16.00 | 2019 | |
| Coopersurgical, INC. | $14.93 | 2023 | Paragard T 380a |
| Agile Therapeutics, INC. | $14.62 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.60 | 2019 | |
| Exeltis, USA INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocelyn Carlo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.